Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 5Terminated 3Completed 3Withdrawn 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 11Head & Neck 6Thoracic 3Gynecologic 2CNS 2Other solid neoplasm 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × nimotuzumab × Thoracic × Clear all
NCT02947386 2023-10-05

Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 1 Completed
7 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02577341 2021-02-11

Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer

Sun Yat-sen University

Phase 2 Completed
122 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01498562 2014-12-02

DATE

Yonsei University

Phase 2 Completed
160 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡